Novozymes A/S (NVZMY) Short Interest Ratio & Short Volume → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free NVZMY Stock Alerts $63.36 +0.65 (+1.04%) (As of 05/17/2024 08:55 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartDividendEarningsFinancialsHeadlinesSEC FilingsShort Interest Novozymes A/S Short Interest DataCurrent Short Volume100 sharesPrevious Short Volume700 sharesChange Vs. Previous Month-85.71%Dollar Volume Sold Short$5,513.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 30, 2024Outstanding Shares468,300,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume6,300 sharesAverage Trading Volume15,751 sharesToday's Volume Vs. Average40% Short Selling Novozymes A/S ? Sign up to receive the latest short interest report for Novozymes A/S and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNVZMY Short Interest Over TimeNVZMY Days to Cover Over TimeNVZMY Percentage of Float Shorted Over Time Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. Novozymes A/S Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024100 shares $5,513.00 -85.7%N/A0 $55.13 4/15/2024700 shares $38,115.07 -56.3%N/A0 $54.45 3/31/20241,600 shares $94,176.00 -55.6%N/A0.1 $58.86 3/15/20243,600 shares $214,200.00 +176.9%N/A0.1 $59.50 2/29/20241,300 shares $73,307.00 -79.7%N/A0 $56.39 2/15/20246,400 shares $341,696.00 +128.6%N/A0.2 $53.39 Get the Latest News and Ratings for NVZMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,900 shares $102,448.00 -9.5%N/A0.1 $53.92 12/31/20232,100 shares $115,300.50 +320.0%N/A0.1 $54.91 12/15/2023500 shares $26,030.00 -61.5%N/A0 $52.06 11/30/20231,300 shares $67,470.00 -93.4%N/A0 $51.90 11/15/202319,700 shares $1.02 million +271.7%N/A0.4 $51.76 10/31/20235,300 shares $238,606.00 +140.9%N/A0.1 $45.02 10/15/20232,200 shares $90,772.00 -81.5%N/A0 $41.26 9/30/202311,900 shares $478,499.00 +600.0%N/A0.1 $40.21 9/15/20231,700 shares $72,352.00 +88.9%N/A0 $42.56 8/31/2023900 shares $39,024.00 -72.7%N/A0 $43.36 8/15/20233,300 shares $151,800.00 -56.6%N/A0.1 $46.00 7/31/20237,600 shares $380,988.00 +590.9%N/A0.4 $50.13 7/15/20231,100 shares $54,868.00 -8.3%N/A0 $49.88 6/30/20231,200 shares $55,860.00 -40.0%N/A0 $46.55 6/15/20232,000 shares $99,680.00 -65.5%N/A0.1 $49.84 5/31/20235,800 shares $279,328.00 +70.6%N/A0.2 $48.16 5/15/20233,400 shares $181,492.00 +88.9%N/A0.1 $53.38 4/30/20231,800 shares $93,600.00 +125.0%N/A0 $52.00 4/15/2023800 shares $40,592.00 -83.7%N/A0 $50.74 3/31/20234,900 shares $250,341.00 +1,533.3%N/A0.2 $51.09 3/15/2023300 shares $14,337.00 -25.0%N/A0 $47.79 2/28/2023400 shares $19,196.00 -42.9%N/A0 $47.99 2/15/2023700 shares $35,217.00 No ChangeN/A0 $50.31 1/31/2023700 shares $36,253.00 -86.3%N/A0 $51.79 1/15/20235,100 shares $260,916.00 +920.0%N/A0.1 $51.16 12/30/2022500 shares $25,230.00 -44.4%N/A0 $50.46 12/15/2022900 shares $46,854.00 -47.1%N/A0 $52.06 11/30/20221,700 shares $98,243.00 +30.8%N/A0.1 $57.79 11/15/20221,300 shares $74,262.50 +8.3%N/A0 $57.13 10/31/20221,200 shares $62,767.20 +100.0%N/A0 $52.31 10/15/2022600 shares $28,674.00 -85.0%N/A0 $47.79 9/30/20224,000 shares $200,200.00 -4.8%N/A0.1 $50.05 9/15/20224,200 shares $222,642.00 +223.1%N/A0.1 $53.01 8/31/20221,300 shares $74,412.00 +62.5%N/A0 $57.24Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. NVZMY Short Interest - Frequently Asked Questions What is Novozymes A/S's current short interest? Short interest is the volume of Novozymes A/S shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 100 shares of NVZMY short. Learn More on Novozymes A/S's current short interest. Is Novozymes A/S's short interest increasing or decreasing? Novozymes A/S saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 100 shares, a decline of 85.7% from the previous total of 700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Novozymes A/S's short interest compare to its competitors? Here is how the short interest of companies in the sector of "basic materials" compare to Novozymes A/S: Nutrien Ltd. (0.86%), Barrick Gold Corp (0.72%), Teck Resources Limited (1.24%), PPG Industries, Inc. (1.08%), Wheaton Precious Metals Corp. (4.06%), DuPont de Nemours, Inc. (1.09%), Franco-Nevada Co. (1.64%), LyondellBasell Industries (1.42%), Agnico Eagle Mines Limited (1.17%), Cameco Co. (4.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Novozymes A/S stock? Short selling NVZMY is an investing strategy that aims to generate trading profit from Novozymes A/S as its price is falling. NVZMY shares are trading up $0.65 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Novozymes A/S? A short squeeze for Novozymes A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NVZMY, which in turn drives the price of the stock up even further. How often is Novozymes A/S's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVZMY, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Nutrien Short Squeeze Barrick Gold Short Squeeze Teck Resources Short Squeeze PPG Industries Short Squeeze Wheaton Precious Metals Short Squeeze DuPont de Nemours Short Squeeze Franco-Nevada Short Squeeze LyondellBasell Industries Short Squeeze Agnico Eagle Mines Short Squeeze Cameco Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NVZMY) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDems have chosen Biden replacement?Paradigm Press